Daily Archives: January 26, 2015

Ninja-c4 Gets a DNA BOMB – Video

Posted: January 26, 2015 at 4:43 am


Ninja-c4 Gets a DNA BOMB
Call of Duty: Advanced Warfare https://store.sonyentertainmentnetwork.com/#!/tid=CUSA00803_00.

By: Demthangz

Follow this link:
Ninja-c4 Gets a DNA BOMB - Video

Posted in DNA | Comments Off on Ninja-c4 Gets a DNA BOMB – Video

Best Class Setup//AW…(Tipps fr DNA Klassen) – Video

Posted: at 4:43 am


Best Class Setup//AW...(Tipps fr DNA Klassen)
Leute, herzlich Willkommen auf meinem Channel. Ich wrde mich ber eine Bewertung und ein Abo freuen. Der Venox Clan Memberliste: Alan - Evolution Julian - PanameraFlow-__ Leo - SyST3M...

By: Morgrave ISN

Read more here:
Best Class Setup//AW...(Tipps fr DNA Klassen) - Video

Posted in DNA | Comments Off on Best Class Setup//AW…(Tipps fr DNA Klassen) – Video

TRIPLE DNA BOMB FAIL I Dual w/ zRaiZr I Info’s ber Team Recore – Video

Posted: at 4:43 am


TRIPLE DNA BOMB FAIL I Dual w/ zRaiZr I Info #39;s ber Team Recore
zRaiZr : http://bit.ly/1yodJnD Team Recore Clanchannel : http://bit.ly/1A9XAAp TS Sponsor : http://bit.ly/1tGMfsi Facebook : https://www.facebook.com/iRazor48 https://www.fa...

By: iRazor48

Excerpt from:
TRIPLE DNA BOMB FAIL I Dual w/ zRaiZr I Info's ber Team Recore - Video

Posted in DNA | Comments Off on TRIPLE DNA BOMB FAIL I Dual w/ zRaiZr I Info’s ber Team Recore – Video

Call of Duty: ROAD TO DNA – Video

Posted: at 4:43 am


Call of Duty: ROAD TO DNA
Call of Duty Advanced Warfare https://store.sonyentertainmentnetwork.com/#!/tid=CUSA00851_00.

By: One Shot Rippers Clan

See more here:
Call of Duty: ROAD TO DNA - Video

Posted in DNA | Comments Off on Call of Duty: ROAD TO DNA – Video

DNA Blood Test Gives Women A New Option For Prenatal Screening

Posted: at 4:43 am

Ultrasound is often used for prenatal screening. It's just one of several prenatal screenings available to pregnant women. iStockphoto hide caption

Ultrasound is often used for prenatal screening. It's just one of several prenatal screenings available to pregnant women.

When Amy Seitz got pregnant with her second child last year, she knew that being 35 years old meant there was an increased chance of chromosomal disorders like Down syndrome. She wanted to be screened, and she knew just what kind of screening she wanted a test that's so new, some women and doctors don't quite realize what they've signed up for.

This kind of test , called cell free fetal DNA testing, uses a simple blood sample from an expectant mother to analyze bits of fetal DNA that have leaked into her bloodstream. It's only been on the market since October of 2011 and is not regulated by the Food and Drug Administration - the FDA does not regulate this type of genetic testing service. Several companies now offer the test, including Sequenom and Illumina. Insurance coverage varies and doctors often only offer this testing to women at higher risk because of things like advanced maternal age.

"I think that I initially heard about it through family and friends," says Seitz. "They had had the option of it given to them by their doctors."

To her, it sounded great. She didn't want an invasive procedure like amniocentesis or chorionic villus sampling (CVS). Those are considered the gold standard for prenatal genetic testing, but doctors must put a needle into the womb to collect cells that contain fetal DNA, which means a small risk of miscarriage.

During amniocentesis, a needle is inserted through a woman's abdomen into the amniotic sac. A sample of fluid is extracted and screened for genetic disorders such as Down syndrome.

"I wasn't interested in going as far as getting an amniocentesis because of the risk associated with that," she explains, "and so when I heard about this test, that was part of the reason that I was most interested in it."

This new way of testing fetal DNA seemed to have already become fairly common where Seitz used to live, in Washington, D.C. But she had recently moved to Alabama, and the clinic she went to there wasn't as familiar with it although when she talked to her doctor, she learned they'd just had a visit from a company's sales representative.

"I think it was a fairly new test for them at that point, but she was interested in pursuing it further to see what needed to be done," Seitz says.

See original here:
DNA Blood Test Gives Women A New Option For Prenatal Screening

Posted in DNA | Comments Off on DNA Blood Test Gives Women A New Option For Prenatal Screening

4. UCSC Genome Browser Tutorial: table browser – Video

Posted: at 4:43 am


4. UCSC Genome Browser Tutorial: table browser
UCSC Genome Browser Tutorial Video 4 A tutorial for the Table Browser, a search tool that retrieves nucleic acid sequences from specified regions of the geno...

By: Sam Allon

Read this article:
4. UCSC Genome Browser Tutorial: table browser - Video

Posted in Genome | Comments Off on 4. UCSC Genome Browser Tutorial: table browser – Video

Comparison: 23andMe and Prometheus Genome Analysis – Video

Posted: at 4:43 am


Comparison: 23andMe and Prometheus Genome Analysis
This video compares the aesthetic and functional aspects of 23andMe and Promethease test reports. It focuses primarily on layout and information provided, wi...

By: Rob Flanagan

Read the original:
Comparison: 23andMe and Prometheus Genome Analysis - Video

Posted in Genome | Comments Off on Comparison: 23andMe and Prometheus Genome Analysis – Video

osu! Tsunamaru – Daidai Genome [Normal] DT HR HD – Video

Posted: at 4:43 am


osu! Tsunamaru - Daidai Genome [Normal] DT HR HD

By: - [ DTHR ] -

Read more:
osu! Tsunamaru - Daidai Genome [Normal] DT HR HD - Video

Posted in Genome | Comments Off on osu! Tsunamaru – Daidai Genome [Normal] DT HR HD – Video

Decoding cancer transcriptomes using public RNA-seq data – Video

Posted: at 4:43 am


Decoding cancer transcriptomes using public RNA-seq data
Speaker: dr. Pieter Mestdagh, Ghent University / Biogazelle, Belgium Event: Biogazelle sponsored RNA-sequencing mini-symposium (Ghent - Belgium, Jan. 14, 2015) Abstract: Genome-wide studies...

By: Biogazelle

Go here to read the rest:
Decoding cancer transcriptomes using public RNA-seq data - Video

Posted in Genome | Comments Off on Decoding cancer transcriptomes using public RNA-seq data – Video

Human Longevity, Inc. Signs Agreement with Genentech for …

Posted: at 4:43 am

LA JOLLA, Calif., Jan. 14, 2015 /PRNewswire/ -- Human Longevity, Inc. (HLI), the human health information technology and health care company, today announced a multi-year agreement with Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), to conduct whole genome sequencing of tens of thousands of de-identified samples from Genentech. HLI, using proprietary tools and unique expertise, will sequence genomes to 30x coverage and analyze the data. Financial details of the agreement were not disclosed.

"We are excited to be working with Genentech so that patient samples can be analyzed according to more precise genetic categories," said J. Craig Venter, Ph.D., HLI CEO and Co-Founder. "At HLI we have built unprecedented capabilities for whole genome sequencing and interpretation to enable a wide array of advances in health care. The application of our capabilities to discover new diagnostics and targeted therapies is one of the most relevant today."

HLI is focused on building the world's most comprehensive integrated human genotype and phenotype database, the HLI Knowledgebase. To achieve that, HLI has established the largest human genome sequencing center in the world, and is sequencing and analyzing complete, 30x coverage genomes using Illumina's HiSeq X Ten sequencing machines. HLI also utilizes Illumina HiSeq 2500 and Pac Bio RS II instruments.

"Genentech's goal is to harness the power of widespread whole genome sequencing to identify new therapeutic targets and diagnostic biomarkers," said James Sabry, senior vice president and global head of Genentech partnering. "We are pleased to join forces with HLI and leverage their expertise in DNA sequencing and analysis along with scientific expertise to accelerate our drug discovery efforts and ultimately bring to market promising new therapies for patients with serious medical conditions."

HLI and Genentech take the privacy and protection of individual's personal information very seriously. All sample and patient data elements are de-identified to remove all personally identifiable information.

About Human Longevity, Inc.HLI, a privately held company headquartered in San Diego, CA was founded in 2013 by pioneers in the fields of genomics and stem cell therapy. Using advances in genomic sequencing, the human microbiome, proteomics, informatics, computing, and cell therapy technologies, HLI is building the world's most comprehensive knowledge base of human genotypes and phenotypes as a basis for a variety of opportunities to help solve aging related disease and human biological decline. HLI will be licensing access to its Knowledgebase to pharmaceutical and biotech companies, academic institutions and medical centers, governments, insurers and physicians, and developing new diagnostics and therapeutics as part of their product offerings. For more information please visit, http://www.humanlongevity.com

Logo- http://photos.prnewswire.com/prnh/20140304/LA76169LOGO

SOURCE Human Longevity, Inc.

RELATED LINKS http://www.humanlongevity.com

Original post:
Human Longevity, Inc. Signs Agreement with Genentech for ...

Posted in Human Longevity | Comments Off on Human Longevity, Inc. Signs Agreement with Genentech for …